Chunguang Liang

7PUBLICATIONS
71CO-AUTHORS
BiomaterialsHaematological tumoursPredictive and prognostic markersExercise physiologyTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 11, 2026
The FAP × CD3 bispecific antibody OMTX305 induces T cell-mediated antitumor effects in patient-derived ex vivo models of solid tumors.

|Jul 18, 2024
Oligoclonal CD4+CXCR5+ T cells with a cytotoxic phenotype appear in tonsils and blood.

Chunguang Liang, Silvia Spoerl, Yin Xiao

|Apr 24, 2024
ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC.

Kathrin Böpple, Yaara Oren, Whitney S Henry

|Mar 27, 2024
Attenuation of fibroblast activation and fibrosis by adropin in systemic sclerosis.

Minrui Liang, Nicholas Dickel, Andrea-Hermina Györfi

|Jul 14, 2021
Engrailed 1 coordinates cytoskeletal reorganization to induce myofibroblast differentiation.

Andrea-Hermina Györfi, Alexandru-Emil Matei, Maximilian Fuchs

|Apr 28, 2021
Select hyperactivating NLRP3 ligands enhance the TH1- and TH17-inducing potential of human type 2 conventional dendritic cells.

Lukas Hatscher, Christian H K Lehmann, Ariawan Purbojo

Pageof 2

Frequent Collaborators

2 joint publications

Meik Kunz

2 joint publications

Walter E Aulitzky

2 joint publications

Jörg H W Distler

2 joint publications

Georg Schett